참고문헌
- Aksoy RT, Turan AT, Boran N, et al (2014). Lack of relation of survivin gene expression with survival and surgical prognostic factors in endometrial carcinoma patients. Asian Pac J Cancer Prev, 16, 6905-10.
- Adida C, Berrebi D, Peuchmaur M, et al (1998). Anti-apoptosis gene, survivin, and prognosis of neuroblastoma [letter]. Lancet, 9106, 882-3.
- Ambrosini G, Adida C, Alteri DC (1997). A novel anti-apotosis gene, Surviving, express in cancer and lymphoma. Nature Med, 8, 917-21.
- Asanuma K, Moriai R, Yajima T, et al (2000). Survivin as a radioresistance factor in pancreatic cancer. Japan J Cancer Res, 11, 1204-9.
- Cryns V, Yuan Y (1999). Proteases to die for. Genes Dev, 11, 1551-70.
- Deveraux QL, Reed JC (1999). IAP family proteins-suppressors of apoptosis. Genes Dev, 3, 239-52.
- Dong Y, Sui L, Watanabe Y, et al (2002). Survivin expression in laryngeal squamous cell carcinomas and its prognostic implications. Anticancer Res, 4, 2377-83.
- Fu SM, Cai JH, Tu ZH, et al (2007). Detection of survivin mRNA in nasopharyngeal carcinoma by real-time fluorescence quantitative RT-PCR. Practical Oncol J, 6, 503-6.
- He X, Song D, Chen SQ, et al (2009). Correlation between the deletion of p16 gene and prognosis of nasopharyngeal carcinoma. Oncol J, 4, 281-3.
- Hu GQ, Qi WW, Wang R (2008). Expression and prognostic significance of survivin and bcl-2 in nasopharyngeal carcinoma. Acta Med Univ Sci Technol Huazhong, 1, 109-11.
- Kato J, Kuwabara Y, Mitani M, et al (2001). Expression of Survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer, 2, 92-5.
- Li YH, Hu CF, Shao Q, et al (2008). Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma. J Translational Med, 1, 1-11.
- Lu CD, Altieri DC, Tanigawa N (1998). Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53accumulation in gastric carcinomas. Cancer Res, 9, 1808-12.
- Qi B, Guo X, Wen YF, et al (2010). Correlation between the gene polymorphism of pathway about radiotherapy or chemotherapy and prognosis nasopharyngeal carcinoma with terminal stage of partial region. Chin J Can Prev Treat, 10, 755-8.
- Shin S, Sung BJ, Cho YS, et al (2001). An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and caspase-7. Biochemistry, 4, 1117-23.
- Tanaka K, Iwamoto S, Gon G, et al (2000). Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res, 6, 127-34.
- Wang HY, Sun BY, Zhu ZH, et al (2011). Eight-signature classifier for prediction of nasopharyngeal carcinoma survival. J Clin Oncol, 24, 4516-25.
- Xu S, Zhang WY (2001). Study on the correlation between the expression of protein p53 at stage III nasopharyngeal carcinoma and its biological behavior, prognosis, p53 gene mutation and the expression of LMP-1. Chin J Pathol, 6, 456-9.
- Xu W, Chang H, Qin CK, et al (2013). Impact of co-transfection with livin and survivin shRNA expression vectors on biological behavior of HepG2 cells. Asian Pac J Cancer Prev, 9, 5467-72.
- Zhang S, Xiao JY, Tian YQ, et al (2004). Overexpression of survivin protein in nasopharyngeal carcinoma: correlation with apoptosis index and the prognosis. Chinese J Otorhinolaryngology-Skull Base Surgery, 4, 196-9.
- Zhao YT, Zhou LY, He BW, et al (2008). Expression of survivin and PCNA protein in nasopharyngeal carcinoma and their clinical significance. Modern Med J China, 9, 18-20.
피인용 문헌
- Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma vol.22, pp.1, 2017, https://doi.org/10.1186/s11658-017-0038-0